This page does not seem to exist…
We apologize for the inconvenience, but the page you were trying to access is not at this address. You can use the links below to help you find what you are looking for.
If you are certain you have the correct web address but are encountering an error, please contact the Site Administration.
Thank you.
You might have been looking for…
- Advocacy pack
- All documents and materials for advocacy work
- May 2016
- Political affairs, new report on first safe dilution and advocacy pack
- Advocacy tool kit
- A selection of materials for use when attending a meeting on behalf of ECHAMP – whether with politicians, policy makers or opinion formers, health stakeholders ...
- Member room documents
- Advocacy pack, confidential communication, etc.
- July and August 2015
- Meeting with the Commissioner, European Parliament CAM Interest Group, upgrade of Advocacy Pack for Members
- Room for Full Members and Extraordinary Partners
- Resources for Full Members: advocacy pack, confidential correspondance, fields of activity documents
- September 2016
- HMPWG, HRI ‘Frequently Asked Questions’
- April 2021
- Membership Assembly 2021, answer to the European Commission's public consultation on the roadmap for the revision of the general pharmaceutical legislation
- September 2017
- HMPWG consultation, ECHAMP response to EASAC statement